Microdosing Ozempic: Benefits, risks and what doctors say
It doesn’t take much these days to fall down a GLP-1 rabbit hole on the internet. TikTok, Instagram,…
New Weight Loss Drugs Preserve Muscle and Cut Fat
Nearly every pharmaceutical company you can name is chasing this tantalizing idea: hang on to your muscles while…
Ozempic earlobes join growing list of cosmetic concerns from GLP-1 drugs
NEWYou can now listen to Fox News articles! As the popularity of GLP-1 drugs continues to climb, significant…
GLP-1 users may be making a major weight-loss mistake, new study suggests
Among those taking GLP-1 medications for weight loss, exercise rates are decreasing, according to new research. The study, set…
Fitness trainer shares why Japan keeps obesity at 6% while US struggles at 43% despite spending billions on weight loss
When it comes to winning the battle against obesity, your surrounding environment might matter far more than your…
American Heart Association launches platform for earlier heart failure risk identification
Nearly 7 million people in the United States are living with heart failure, and that number is expected to…
Hormone-disrupting chemicals found in breast milk and infants’ urine
Endocrine-disrupting chemicals (EDCs) that interfere with hormones were found in breast milk and in the urine of children…
Study finds gaps in guideline-based testosterone prescribing practices
Only a small number of men who were prescribed testosterone therapy received appropriate, guideline-concordant diagnostic testing, according to a study…
A new wave of weight-loss therapies aims to be better than today’s GLP-1s
Last Updated: June 7, 2026 at 10:18 a.m. ETFirst Published: June 6, 2026 at 2:53 p.m. ET One of the…
South Asia and Southeast Asia lead worldwide in taxing sugary drinks, study finds
Researchers have found that sugar-sweetened beverage tax legislation has risen globally, with South Asia leading in adoption. The…
Study finds indoor cats do not trigger child asthma flares
Asthma is the most common chronic disease and one of the main causes of hospitalization among children. The…
GLP-1 medicines may cut clot-related risks in chronically inflamed patients
A large real-world analysis suggests GLP-1 receptor agonists may offer clot-related and survival benefits in a chronically inflamed,…